A Pragmatic trial of Ibuprofen, Paracetamol and Steam

ISRCTN ISRCTN38551726
DOI https://doi.org/10.1186/ISRCTN38551726
EudraCT/CTIS number 2006-005740-83
Secondary identifying numbers Protocol 4; 2006-005740-83
Submission date
14/01/2009
Registration date
12/03/2009
Last edited
30/06/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Prof Paul Little
Scientific

Primary Medical Care
Aldermoor Health Centre
Aldermoor Close
Southampton
SO16 5ST
United Kingdom

Phone +44 (0)2380 241060
Email p.little@soton.ac.uk

Study information

Study design3 x 2 x 2 randomised factorial controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA pragmatic randomised trial of ibuprofen, paracetamol, steam and delayed prescribing for patients with respiratory tract infections in Primary Care
Study acronymPIPS
Study hypothesisTo assess, in a primary care setting, in patients with respiratory tract infection (RTI), whether:
1. There is a difference in the effectiveness between three different antipyretic regimes: ibuprofen treatment, paracetamol treatment and combined ibuprofen and paracetamol treatment
2. Regular antipyretic dosing gives significantly better symptom and temperature control than 'as required' dosing
3. Regular inhalation with steam further improves symptom control
4. There are any differences in antibiotic use and acceptability according to different methods of delaying antibiotic use
Ethics approval(s)Southampton and South West Hampshire REC (A) gave approval on the 12th January 2007 (ref: 06/Q1702/154)
ConditionRespiratory tract infection
InterventionPatients will be randomised to receive one of three kinds of medication advice, one of two kinds of dosing advice and one of two kinds of steam advice.

1. Medication advice:
1.1. Paracetamol: participants will be advised to use paracetamol as their only antipyretic medication
1.2. Ibuprofen: participants will be advised to use ibuprofen as their only antipyretic medication
1.3. Combined paracetamol and ibuprofen: participants will be advised to use paracetamol and ibuprofen

2. Dosing advice:
2.1. Regular dosing: advice to take the medication(s) four times per day (irrespective of whether symptoms or fever have returned)
2.2. As required dosing: advice to take medication(s) as required by symptoms up to a maximum of four doses per day

3. Steam Advice:
3.1. Steam: subjects will be asked to inhale steam for 5 minutes, three times per day. Adults will be instructed to place a towel over their head over a bowl of recently boiled water. Children will be instructed to sit in a steamy room (made steamy by running a hot shower, or boiling a kettle in the room). Participants will receive written and verbal instructions at the beginning of the study.
3.2. No Steam: subjects will be asked not to use steam inhalation

Delayed prescription:
1. Patient led: the patient is given antibiotics and asked to wait to use them
2. Post-dating: the patient is given antibiotics, but post-dated
3. Collection: instructions to wait but can request antibiotics from front desk
4. Recontact/phone: patient is asked to contact/phone the surgery to leave message for doctor/nurse regarding a request for antibiotics, and able to come to reception
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Ibuprofen, paracetamol
Primary outcome measureMean symptom severity during the first 3 days (as measured by symptom diary).
Secondary outcome measures1. Side effects: the symptom diary will allow documentation of adverse events (e.g. rash, diarrhoea, vomiting, abdominal pain)
2. Health service resource use: the diary will document contacts with the health service - including NHS direct, the GP surgery and, secondary care - and any prescribed medication. The notes will be reviewed to confirm prescribed medication and contact with primary and secondary care.
3. Axillary temperature: axillary temperature will be measured by tempadot thermometer twice daily for three days
Overall study start date01/02/2009
Overall study end date31/12/2013

Eligibility

Participant type(s)Patient
Age groupOther
SexBoth
Target number of participants400 - 504
Participant inclusion criteria1. Aged 3 years and over, either sex
2. Presenting to a General Practitioner (GP) or nurse with an RTI diagnosed by the health professional (acute cold, influenza, sore throat, otitis media, sinusitis, croup, or lower respiratory tract infection)
Participant exclusion criteria1. Active or previous peptic ulceration
2. Hypersensitivity to aspirin ibuprofen or paracetamol
3. Inability to measure temperature or complete outcome measures (e.g. parents visually impaired, psychosis, severely depressed)
4. Patients requiring hospital admission (e.g. suspected meningitis, severe pneumonia, epiglottitis, Kawasaki's disease, etc.)
5. Patients with known immune deficiency (where the course of illness and symptomatic response might be modified)
6. Pregnancy or breastfeeding
Recruitment start date01/02/2009
Recruitment end date31/12/2013

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Primary Medical Care
Southampton
SO16 5ST
United Kingdom

Sponsor information

University of Southampton (UK)
University/education

c/o Martina Prude
Legal Services - Research Governance Office
Highfield
Southampton
SO16 5ST
England
United Kingdom

Website http://www.soton.ac.uk/
ROR logo "ROR" https://ror.org/01ryk1543

Funders

Funder type

Government

National Institute for Health Research (NIHR) (UK) - Programme Grant for Applied Research (PGfAR) programme: PRIME Programme Grant (ref: RP-PG-0407-10098)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 25/10/2013 Yes No
Results article results 06/03/2014 Yes No